Sign in
4/A

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-034314

Zawel Leigh sold 28,118 shares at an average $26.77 ($752,850)

From the SEC's structured data for this filing

Trades in this filing

Zawel Leigh

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-09 Sale : show line 1 in the form −19,504 $26.52 $517,246 130,256 D
2021-08-09 Sale : show line 2 in the form −1,700 $27.11 $46,087 128,556 D
2021-08-10 Sale : show line 3 in the form −1,906 $26.50 $50,509 126,650 D
2021-08-10 Sale : show line 4 in the form −3,191 $27.34 $87,242 123,459 D
2021-08-10 Sale : show line 5 in the form −1,817 $28.49 $51,766 121,642 D
Open-market sales · 28,118 sh · avg $26.77 · $752,850
Loading xslF345X03/doc4a.xml…